Back to search
FDAFDA · Food and drugs·Recall number Z-2286-2025

Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEE INS, 7R 16MM, VE Model/Catalog Number: 342-16-707 Product Description: Enovis knee devices are intended for treatment of patients who are candidates for knee arthroplasty per the Indication for use. While total knee replacements are not intended to withstand activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients.

Published August 20, 2025 · Recall initiated: July 9, 2025

Summary

FDA records medical device Class II recall Z-2286-2025, published August 20, 2025 and initiated July 9, 2025. Recalling firm: Encore Medical, LP; Status: Ongoing; Reported quantity: 40 implants; Lot: Lot Code: Item: 342-16-707 GTIN: 00888912167642 Lot: 161T1053, 161T1054. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Knee implants contain incorrect labeling (size and/or side incorrect)

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Encore Medical, LP
Distributor
US Nationwide distribution in the states of AL, AZ, CA, CO, FL, IA, IL, IN, KS, LA, NY, TN, TX.
Lot
Lot Code: Item: 342-16-707 GTIN: 00888912167642 Lot: 161T1053, 161T1054
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEE INS, 7R 16MM, VE Model/Catalog Number: 342-16-707 Product Description: Enovis knee devices are intended for treatment of patients who are candidates for knee arthroplasty per the Indication for use. While total knee replacements are not intended to withstand activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients. recalled?

Yes. FDA published recall Z-2286-2025 on August 20, 2025. Reported hazard: Knee implants contain incorrect labeling (size and/or side incorrect)

What should I do if I have this product?

Voluntary: Firm initiated · Letter